DrugPatentWatch Database Preview

Testosterone undecanoate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

What are the generic drug sources for testosterone undecanoate and what is the scope of testosterone undecanoate patent protection?
Testosterone undecanoate is the generic ingredient in one branded drug marketed by Endo Pharms Inc and is included in one NDA. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Testosterone undecanoate has fifty-one patent family members in thirty-seven countries.

There are sixty-three drug master file entries for testosterone undecanoate. One supplier is listed for this compound.

Summary for testosterone undecanoate

International Patents:	51
US Patents:	2
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	63
Suppliers / Packagers:	1
Bulk Api Vendors:	44
Clinical Trials:	764
Patent Applications:	1,035
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for testosterone undecanoate
DailyMed Link:	testosterone undecanoate at DailyMed

Pharmacology for testosterone undecanoate

Ingredient-type	Androstanes
Drug Class	Androgen
Mechanism of Action	Androgen Receptor Agonists

Synonyms for testosterone undecanoate

(17-beta)-3-Oxoandrost-4-en-17-yl undecanoate
(17\|A)-17-[(1-\| xoundecyl)oxy]androst-4-en-3-one
(17beta)-3-Oxoandrost-4-en-17-yl undecanoate
(1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl undecanoate
(1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.0?,?.0??,??]heptadec-6-en-14-yl undecanoate
(1S,2R,10R,11S,14S,15S)-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-YL UNDECANOATE
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate
17beta-Hydroxyandrost-4-en-3-one undecanoate
3-Oxoandrost-4-en-17beta-yl undecanoate
4-08-00-00981 (Beilstein Handbook Reference)
5-.alpha.-Androstan-3-one, 17-.beta.-hydroxy-, undecanoate
5-alpha-Androstan-3-one, 17-beta-hydroxy-, undecanoate
5949-44-0
949T440
AC1L22PV
AK115043
AKOS016010255
Ambotz105300-28-5
AN-11881
Andriol
Andriol (TN)
Andriol Testocaps
Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17-beta)-
Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-, (17beta)-
Androst-4-en-3-one, 17-((1-oxoundecyl)oxy)-(17beta)
Androst-4-en-3-one, 17-[(1-oxoundecyl)oxy]-, (17.beta.)-
BAY 86-5037
BRN 3176734
C-22555
CC-34823
CHEBI:135741
CHEMBL2107067
CLR-610
CS-4342
D02AXG
D06087
EINECS 227-712-6
GS-6598
H16A5VCT9C
HY-B0626
Jatenzo
LP095070
LS-148824
MFCD00468114
MolPort-003-850-422
Nebido
Nebido-R
Org 538
ORG-538
Pantestone
PL000411
Reandron 1000
Restandol
Restandol (TN)
Rextoro
SC-16124
SCHEMBL147620
T undecanoate
Testosterone (undecanoate)
Testosterone undecanoate (USAN)
Testosterone undecanoate [USAN]
Testosterone Undeconate
Testosterone undecylate
Testosterone, undecanoate
Testosterone, undecanoate (ester)
Testosteroneundecanoate
Testrosterone undecanoate
UDSFVOAUHKGBEK-CNQKSJKFSA-N
Undestor
UNII-H16A5VCT9C
W-105318
ZINC8214690

US Patents and Regulatory Information for testosterone undecanoate

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Endo Pharms Inc	AVEED	testosterone undecanoate	INJECTABLE;INTRAMUSCULAR	022219-001	Mar 5, 2014		RX	Yes	Yes	➤ Try a Free Trial	➤ Try a Free Trial				➤ Try a Free Trial
Endo Pharms Inc	AVEED	testosterone undecanoate	INJECTABLE;INTRAMUSCULAR	022219-001	Mar 5, 2014		RX	Yes	Yes	➤ Try a Free Trial	➤ Try a Free Trial	Y			➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration